Apart from the general issues just mentioned, the involvement of HIF-1α, particularly in the progression of obesity and type 2 diabetes-associated NAFLD, has been traditionally related to its role (and then of HIF1) in regulating the expression of the genes involved in glucose and lipid metabolism. The gene discussed is HIF1A; the disease is metabolic dysfunction-associated steatotic liver disease.